Understanding Kratom Use: A Guide for Healthcare Providers

被引:41
作者
Swogger, Marc T. [1 ]
Smith, Kirsten E. [2 ]
Albert, Garcia-Romeu [3 ]
Grundmann, Oliver [4 ,5 ]
Veltri, Charles A. [4 ]
Henningfield, Jack E. [3 ,6 ]
Busch, Lorna Y. [1 ]
机构
[1] Univ Rochester Med Ctr, Dept Psychiat, Rochester, NY USA
[2] Natl Inst Drug Abuse Intramural Res Program, Translat Addict Med Branch, Baltimore, MD USA
[3] Johns Hopkins Univ Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA
[4] Midwestern Univ Coll Pharm, Dept Pharmaceut Sci, Glendale, AZ USA
[5] Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL USA
[6] Pinney Associates Bethesda, Maryland, NY USA
关键词
kratom (Mitragyna speciosa Korth); emerging therapeutic agents; pain; mood and anxiety; substance use and misuse; MITRAGYNA-SPECIOSA; WITHDRAWAL SYMPTOMS; PRODUCTS SOLD; UNITED-STATES; ABUSE; PHARMACOLOGY; 7-HYDROXYMITRAGYNINE; PHARMACOKINETICS; ALTERNATIVES; METABOLITE;
D O I
10.3389/fphar.2022.801855
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Kratom (Mitragyna speciosa Korth., Rubiaceae) is a plant native to Southeast Asia, where it has been used for centuries as a mild stimulant and as medicine for various ailments. More recently, as kratom has gained popularity in the West, United States federal agencies have raised concerns over its safety leading to criminalization in some states and cities. Some of these safety concerns have echoed across media and broad-based health websites and, in the absence of clinical trials to test kratom's efficacy and safety, considerable confusion has arisen among healthcare providers. There is, however, a growing literature of peer-reviewed science that can inform healthcare providers so that they are better equipped to discuss kratom use with consumers and people considering kratom use within the context of their overall health and safety, while recognizing that neither kratom nor any of its constituent substances or metabolites have been approved as safe and effective for any disease. An especially important gap in safety-related science is the use of kratom in combination with physiologically active substances and medicines. With these caveats in mind we provide a comprehensive overview of the available science on kratom that has the potential to i clarity for healthcare providers and patients. We conclude by making recommendations for best practices in working with people who use kratom.
引用
收藏
页数:12
相关论文
共 105 条
[1]  
Abdullah MFIL, 2021, CLIN TOXICOL, V59, P400, DOI 10.1080/15563650.2020.1812627
[2]  
Adkins JE, 2011, CURR TOP MED CHEM, V11, P1165
[3]   A Case of Kratom-induced Seizures [J].
Afzal, Hasnain ;
Esang, Michael ;
Rahman, Sabreen .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (01)
[4]   Mitragyna speciosa use in the northern states of Malaysia: A cross-sectional study [J].
Ahmad, Kamarudin ;
Aziz, Zoriah .
JOURNAL OF ETHNOPHARMACOLOGY, 2012, 141 (01) :446-450
[5]   Type of Multimorbidity and Complementary and Alternative Medicine Use among Adults [J].
Alwhaibi, Monira ;
Bhattacharya, Rituparna ;
Sambamoorthi, Usha .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
[6]  
American Kratom Association, 2019, INCR CONS US KRAT US
[7]  
[Anonymous], 2016, PR Newswire
[8]  
Anwar M, 2016, MMWR-MORBID MORTAL W, V65, P748, DOI 10.15585/mmwr.mm6529a4
[9]  
Babin J., 2018, FDA FAILS FOLLOW SCI
[10]   Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010 [J].
Bachhuber, Marcus A. ;
Saloner, Brendan ;
Cunningham, Chinazo O. ;
Barry, Colleen L. .
JAMA INTERNAL MEDICINE, 2014, 174 (10) :1668-1673